In August 2018, the Hyperbaric Facility at UI Hospitals & Clinics officially began enrolling patients into a multicenter study known as the Hyperbaric Oxygen Brain Injury Treatment Trial (HOBIT). UI Hospitals & Clinics is one of 20 facilities around the nation involved with this study, which investigates what pressure and duration of treatment best suits the needs of this patient population. Currently, eight specific treatment arms are being investigated during the second phase of this trial. Treatment arms are randomly assigned upon successful enrollment in the study. 

The Hyperbaric Facility at UI Hospitals & Clinics was considered a favorable candidate for this study based on the ability to care for critically ill patients in the HBO chamber. Dedicated clinicians and the leadership of medical director Merete Ibsen, MD, clinical assistant professor of anesthesia–hyperbaric oxygen therapy, and site investigating physician Nicholas Mohr, MD, MS, clinical associate professor of emergency medicine, anesthesia–critical care medicine, and epidemiology, have been vital to UI Health Care’s participation in this innovative study. 

 Merete Ibsen, MD     Nicholas Mohr, MD, MS

Read the full story here.